Ubs Asset Management Americas Inc Enanta Pharmaceuticals Inc Transaction History
Ubs Asset Management Americas Inc
- $381 Billion
- Q3 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 170,615 shares of ENTA stock, worth $1.46 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
170,615
Previous 198,212
13.92%
Holding current value
$1.46 Million
Previous $2.57 Million
31.17%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding ENTA
# of Institutions
110Shares Held
21.1MCall Options Held
4.8KPut Options Held
4.6K-
Farallon Capital Management LLC San Francisco, CA2.11MShares$18 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.98MShares$17 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$15.8 Million0.0% of portfolio
-
Krensavage Asset Management, LLC New York, NY1.5MShares$12.8 Million8.7% of portfolio
-
Morgan Stanley New York, NY1.1MShares$9.44 Million0.0% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $177M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...